The Latin America, Middle East and Africa Autoinjectors Market would witness market growth of 18.7% CAGR during the forecast period (2020-2026).
Epinephrine is considered the first line of treatment for allergic reactions or anaphylaxis. Pharmaceutical companies are bringing technologically advanced epinephrine autoinjectors (EAIs) treatment of anaphylaxis. With the advancement in technology including portable devices, innovative designs, autoinjectors with two auto-injectable doses in one device, autoinjectors made with a 0.5- or 0.75-mg dose of epinephrine for larger adults, the autoinjectors are experiencing higher rate of adoptability.
Also, autoinjectors made with a 0.1-mg dose of epinephrine for infants, autoinjectors with enhanced temperature stability and extended shelf life for epinephrine, weather-resistant casing, and devices that can update patients that the dosage was successfully delivered makes the device more user friendly. Factors that are being focused on for improvement of autoinjectors are removal force of safety cap, override force, ejection time, ejection dosage, needle activation force, needle length, dose setting & audible click detection. These technological advancements are anticipated to drive the adoption of autoinjectors significantly in the coming years.
The existing COVID-19 pandemic has brought about the implementation of a new set of protocols that target to decrease patient visits to hospitals and clinics if it is not emergency conditions in order to prevent the spread of the virus. In such a situation, the inclination for home-use autoinjectors has increased among patients who are suffering from allergies and chronic illnesses. This also safeguards susceptible high-risk populations from exposure to the virus while visiting to hospital.
Autoinjectors are being advanced to support improved concentrations and viscosity of drugs to lessen administration frequency, therefore growing adherence to acclaimed drug protocols. These factors facilitate an opportunity for the growth of the market of autoinjectors in the present COVID-19 scenario.
Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.
Scope of the Study
Market Segments covered in the Report:
• Disposable autoinjectors
• Reusable autoinjectors
• Rheumatoid Arthritis
• Multiple Sclerosis
• Other Applications
By End Use
• Hospitals & Clinics
• Home care settings
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Eli Lilly and Company
• GlaxoSmithKline PLC (GSK)
• Merck Group
• Sanofi S.A.
• Becton, Dickinson and Company
• Teva Pharmaceuticals Industries Ltd.
• Amgen, Inc.
• Ypsomed AG
• AbbVie, Inc.
• Biogen, Inc.
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The South and Central America microplate readers market is expected to reach US$ 33.74 million by 2027 from US$ 27.19 million in 2019; it is estimated to grow with a CAGR of 2.8% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing research and development in the pharmaceutical industry and...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
The Latin America, Middle East and Africa Enzymes Market would witness market growth of 9.33% CAGR during the forecast period (2021-2027). Catalytic hydrolysis of starch requires amylase and cellulase in order to create sugar. The growth of the global enzymes market would be driven by the rising utilization of carbohydrases as an ingredient...
The Latin America, Middle East and Africa Electronic Clinical Outcome Assessment Solution Market (ECOA) would witness market growth of 20.2% CAGR during the forecast period (2020-2026). A Patient’s mental state, the prognosis of a disease, illness conditions, and the role of a patient in that situation can be evaluated with the help...
The Asia Pacific Autoinjectors Market would witness market growth of 19.1% CAGR during the forecast period (2020-2026). Most of the autoinjectors are single-use, disposable, spring-loaded syringes. The autoinjectors are designed in such a way that it makes them easy to use and are planned for self-administration by patients, or delivered...
The North America Autoinjectors Market would witness market growth of 16.9% CAGR during the forecast period (2020-2026). As per the US National Health Council, approximately 75% of the healthcare expenditure of the nation is used in the treatment of chronic diseases, including diabetes. The main share of expenditures is acquired by...
The Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing includeincreasing focus on pre-clinical development services...
The Future-Proof Pharma Labels market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing includes increasing demand of personalized medicine and treatments, rising counterfeiting cases and adoption of electronic...
The Latin America, Middle East and Africa Alginate Market would witness market growth of 8.83% CAGR during the forecast period (2020-2026). Development of the food & beverage sector in BRICS and the Middle East due to expanding domestic consumption is expected to augment the consumption of alginates. The rising demand for convenience...
United Arab Emirates
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.